ArticleCancers2014

Gefitinib plus interleukin-2 in advanced non-small cell lung cancer patients previously treated with chemotherapy.

Melissa Bersanelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.